In 2003, the Boston University Medical Center (BUMC) was awarded a $128 million grant from the National Institutes of Health to build one of two high- and maximum- containment laboratory facilities for research on biological pathogens. The National Emerging Infectious Disease Laboratories (NEIDL) are meant to support the National Institute of Allergy and Infectious Diseases and biodefense research agenda, conducting research to develop new approaches to treating, preventing, and diagnosing a variety of viral diseases. Diseases and agents to be studied include viruses and bacteria that occur naturally and cause infections or that could be used in deliberate attacks. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1 reviews the proposed risk assessment plans associated with operating the NEIDL and provides input on key milestones in the development of supplementary risk assessment.
Table of Contents
|Attachment A Committee on Continuing Assistance to the National Institutes of Health on Preparation o fAdditional Risk Assessments for the Boston University NEIDL||10-14|
|Attachment B MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA||15-16|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1...